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Abstract
Background: Previous results from studies on the relationship between coffee/caffeine consumption and risk of urinary
incontinence (UI) are inconclusive. We aim to assess this association using a meta-analysis of observational studies.
Methods: Pertinent studies were identified by searching electronic database (Embase, PubMed and Web of Science)
and carefully reviewing the reference lists of pertinent articles until July 2015. Random-effects models were used to
derive the summary ORs and corresponding 95 % CIs.
Results: Seven studies (one case-control, two cohort and four cross-sectional) were included in our meta-analysis.
The summary ORs for any versus non-consumption were 0.75 (95 % CI 0.54–1.04) for coffee and 1.29 (95 % CI 0.
94–1.76) for caffeine consumption. Compared with individuals who never drink coffee, the pooled OR of UI was
0.99 (95 % CI 0.83–1.18) for regular coffee/caffeine drinkers. Coffee/caffeine consumption was not associated with
moderate to severe UI (OR 1.18, 95 % CI 0.88–1.58). In stratified analyses by gender, no significant association was
found between UI risk and coffee/caffeine consumption in both men (OR 0.99, 95 % CI 0.42–2.32) and women
(OR 0.92, 95 % CI 0.80–1.06). By subtype, the pooled ORs were 1.01 (95 % CI 0.86–1.19) for stress UI, 0.99 (95 % CI
0.84–1.16) for urge UI and 0.93 (95 % CI 0.79–1.10) for mixed UI.
Conclusions: This meta-analysis found no evidence for an association between coffee/caffeine consumption and
the risk of UI.
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Background
Urinary incontinence (UI) is a common condition with
significant impact on overall health and quality of life. It
has been estimated that UI prevalence ranged from 5 to
21 % among community dwelling United States men
[1–4]. However, UI prevalence estimates differ consid-
erably due to the definition adopted and ranges between
10 % and 40 % among community-dwelling women [5–8].
Although UI is only a symptom of several conditions, as-
certaining risk factors would be helpful for identifying
high-risk persons and avoidable environmental causes. As
for initial UI treatment, lifestyle changes such as fluid
modification are strongly recommended.
Coffee and caffeine (coffee/caffeine) are one of the
most common beverages worldwide, especially among
western countries; thus, investigating its association with
various diseases has important public health implica-
tions. The relationships between coffee/caffeine and risk
of UI have been reported in many studies. However,
present epidemiological evidence is inconsistent consid-
ering the relationships between coffee/caffeine consump-
tion and the risk of stress, urge and mixed UI. Bortolotti
et al. observed no association between coffee and risk of
UI in 2000 [9]. Since then, several other studies have
been published with inconclusive results [10–12]. For in-
stance, Tettamanti reported that women who often
drank coffee had a lower risk of any UI compared to
women who did not drink coffee [13]. However, Davis
noticed that caffeine consumption was associated with
moderate to severe UI in United States men [12].
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In order to define the possible associations between
coffee/caffeine intake and the risk of UI, we performed a




In performing this meta-analysis, we abided by the
Meta-Analysis of Observational Studies in Epidemiology
(MOOSE) [14] and preferred reporting items for system-
atic reviews and meta-analyses (PRISMA) [15] guide-
lines. Three electronic databases (Medline, Embase and
Web of Science) until July 2015 were used for systematic
literature search, and search terms included coffee, caf-
feine, drink, beverage, risk and urinary incontinence. We
did not set language or other restrictions in the litera-
ture search. As this manuscript is a meta-analysis of
available studies, it does not involve ethics and require
written informed consent from participants.
Inclusion criteria
The present meta-analysis only included studies which
met the following inclusion criteria: (1) the exposure of
interest was coffee or caffeine intake; (2) the outcome of
interest was UI; (3) the study design was observational;
(4) the study reported adjusted risk estimates with corre-
sponding 95 % CIs for the relationship between coffee/
caffeine consumption and risk of UI.
Data extraction
According to the guidelines for meta-analysis [14], two
reviewers independently carried out eligibility evalu-
ation and data extraction. We collected detailed infor-
mation including year of publication, the name of first
author, study design, age and gender of participants,
number of cases, exposure, sample size and multivariate
adjusted ORs and 95 % CIs for each category of coffee/
caffeine intake.
Statistical analysis
It has been stated that when the outcome was rare, rela-
tive risks and ORs could provide similar estimates of risk
[16]. In this present meta-analysis, ORs were adopted as
a common measure of the association between coffee or
caffeine intake and UI risk. In all included studies, the
highest level of coffee or caffeine intake was defined as
‘regularly drink coffee’, and the lowest level of coffee or
caffeine intake was defined as ‘never drink coffee’. Not-
ably, we only adopted the adjusted OR for this meta-
analysis. We derived summary OR estimates with 95 %
CIs using the method of DerSimonian and Laird.
To assess heterogeneity among studies, we used the
Cochran Q and I2 statistics. Subgroup analyses stratified
by gender, extent and type of UI were also carried out to
explore potential sources of heterogeneity. We evaluated
publication bias using a funnel plot and the test pro-
posed by the Begg’s adjusted rank correlation test and
by the Egger’s regression test [17, 18]. We carried out
statistical analyses using STATA, version 11.0 (STATA,




The workflow of the study review is summarized in
Fig. 1. A total of 259 studies were retrieved from the ini-
tial literature search (61 from the Medline, 167 from the
EMBASE, and 31 from the Web of Science). After ex-
cluding 249 studies based on title and abstract reading,
we reviewed the full texts of the remaining 10 potentially
pertinent articles. Finally, seven studies [9–13, 19, 20]
which stated the relationship between coffee/caffeine in-
take and risk UI were included in our meta-analysis. The
characteristics of the included studies are shown in
Table 1. Among the seven included studies, three re-
ported the data of coffee consumption and four reported
caffeine consumption.
Coffee/caffeine consumption and UI risk
The results combining the ORs for the risk of UI associ-
ated with coffee/caffeine consumption was summarized in
Fig. 2. The summary OR for any versus non-consumption
were 0.75 (95 % CI 0.54–1.04) for coffee and 1.29 (95 % CI
0.94–1.76) for caffeine consumption. When combining
coffee and caffeine, the summary OR was 0.99 (95 % CI
0.85–1.16) with statistically significant heterogeneity
among studies (I2 = 89.1 %, p = 0.000). Additionally,
Fig. 1 Flowchart of selection of studies for inclusion in the meta-
analysis on coffee/caffeine consumption and UI risk
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compared with individuals who never drink coffee, the
pooled OR of UI was 0.99 (95 % CI 0.83–1.18) for regular
coffee/caffeine drinkers (Fig. 3).
Coffee /caffeine consumption and incidence of moderate/
severe UI
Three studies provided results on risk of moderate/
severe UI [10, 12, 20], and one study reported the
risk of frequent UI among women with daily caffeine
intakes [11]. In this subgroup meta-analysis, frequent
UI was also regarded as moderate/severe UI. The
summary OR was 1.18 (95 % CI 0.88 to 1.58) with
statistically significant heterogeneity among studies
(I2 = 86.9 %, p = 0.000) (Fig. 4).
Coffee /caffeine consumption and incidence of UI by sex
Two articles reported data on risk of UI specific for gender
[9, 19]; one article consisted entirely of men [12] and four
articles consisted entirely of women [10, 11, 13, 20]. In
stratified analyses by gender, we did not observe any
Table 1 Main characteristics of included studies





Bortolotti, 2000 Italy Cross-sectional ≥50 (M)
≥40 (F)
Both 408 2721 (M) / 2767 (F) Coffee Age
Hannestad, 2003 Norway Cross-sectional ≥20 Female 6876 27,936 Coffee Age, BMI and smoking
Jura, 2011 USA Cohort 37 to 79 Female 15,683 65,176 Caffeine Age, cohort, parity, BMI, cigarette
smoking, race, diabetes, total fluid
intake and physical activity
Tettamanti, 2011 Sweden Cohort 19 to 47 Female / 14,094 Coffee Age, parity, BMI, smoking and
educational level
Hirayama, 2012 Japan Case-control 40 to 75 Both 131 683 (M)/298 (F) caffeine Age, BMI, smoking status, alcohol
drinking, physical activity level, total
fluid intake and presence of
co-morbidity
Gleason, 2013 USA Cross-sectional ≥20 Female 1767 4309 Caffeine Age, race/ethnicity, poverty income
ratio, BMI, self-rated health status,
major depression, chronic diseases,
alcohol use, water intake, total dietary
moisture intake and reproductive
factors in women including vaginal
deliveries
Davis, 2013 USA Cross-sectional ≥20 Male 511 3960 Caffeine Age, race/ethnicity, education, BMI,
vigorous activity, poverty-to income
ratio, chronic disease, health status,
depression, alcohol intake, water
intake and total moisture intake
Fig. 2 Pooled OR of UI for any versus non-consumption of coffee/caffeine
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association between coffee/caffeine intake and risk of UI in
both men (summary ORs, 0.99; 95 % CI, 0.42–2.32) and
women (summary ORs, 0.92; 95 % CI, 0.80–1.06) (Fig. 5).
Coffee /caffeine consumption and risk of UI by subtype
For stress UI, the combined OR was 1.01 (95 % CI
0.86–1.19) (Fig. 6). For urge UI, the summary OR
was 0.99 (95 % CI 0.84–1.16). For mixed UI, the
pooled OR was 0.93 (95 % CI 0.79 to 1.10). For the
different subtypes of incontinence, we did not observe
significant association between coffee/caffeine intake
and risk of UI.
Sensitivity analysis
As for sensitivity analysis, we removed one study at a time
and analyzed the rest. After excluding the study which
carried the most weight [11], the OR was 1.01 (95 % CI
0.77–1.32). After excluding the study which carried the
least weight [19], the OR was 0.98 (95 % CI 0.83–1.16).
Publication bias
No funnel plot asymmetry was observed for the relation-
ship between coffee/caffeine and UI. P values for Egger’s
regression asymmetry test was 0.998 and the Begg’s ad-
justed rank correlation test was 0.764, indicating a low
probability of publication bias (Fig. 7).
Discussion
To our knowledge, this is the first meta-analysis to ex-
plore the association between coffee/caffeine intake and
UI. We observed that coffee/caffeine consumption was
not significantly associated with risk of overall UI. After
deleting one study at a time and analyzing the rest, the
summary OR ranged from 1.01 (95 % CI 0.77–1.32) to
0.98 (95 % CI 0.83–1.16). When evaluating the severity
of UI symptoms, we found no relationship between cof-
fee/caffeine consumption and moderate/severe UI. More-
over, coffee/caffeine consumption was not associated with
types of UI (stress, urge, and mixed UI) when controlling
for other UI risk factors.
Fig. 3 Pooled OR of UI for regular versus non-consumption of coffee/caffeine
Fig. 4 Pooled OR of moderate/severe UI for coffee/caffeine consumption
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Creighton and Stanton observed a statistically signifi-
cant increase in detrusor pressure on bladder filling fol-
lowing administration of caffeine in women with
detrusor instability [21]. Tomlinson et al. reported that
the relationship between a decrease in the amount of
dietary caffeine consumed and fewer daytime episodes
of involuntary urine loss approached significance [22].
Thus, the relationship between lower urinary tract dys-
function and coffee/caffeine intake might be plausible.
Considering that coffee/caffeine may exacerbate urinary
incontinence, physicians often recommend a reduction
in coffee/caffeine intake for individuals with incontin-
ence symptoms.
To ascertain the impact of cumulative dose of coffee/
caffeine intake on the risk of UI, we used a meta-analytic
approach to estimate overall OR and 95 % CIs for regu-
lar coffee/caffeine drinkers versus individuals who
seldom drank coffee/caffeine. In the seven studies, the
lowest level of coffee/caffeine intake was defined as
‘never drink coffee’, whereas the highest level of coffee/
caffeine intake was defined as ‘regularly drink coffee’. Of
note, regular coffee/caffeine drinkers experienced an
Fig. 5 Forest plots of UI risk by gender associated with coffee/caffeine consumption
Fig. 6 Forest plots of UI risk by subtype associated with coffee/caffeine consumption
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increased risk of 18 % for UI. However, no significant
difference was found between the two groups.
According to the Incontinence Severity Index or
other items, UI was categorized as “any” or “moderate/
severe”. Three studies provided results on risk of mod-
erate/severe UI [10, 11, 20], and one study reported the
risk of frequent UI among women with daily caffeine
intakes [12]. Jura stated that frequent incontinence was
UI at least once per week among incident cases. Thus,
frequent UI was also regarded as moderate/severe UI in
the subgroup meta-analysis.
We also explored the association between coffee/
caffeine consumption and incidence of UI by gender.
Tettamanti and colleagues reported that women with
a high coffee intake were at lower risk of any urinary
incontinence compared with women not drinking cof-
fee [13]. Gleason et al. found that caffeine intake ≥
204 mg/day was associated with any UI in United States
women [20]. A case-control study of Japanese adults failed
to find an association between coffee/caffeine intake
and incidence of UI [19]. Davis et al. demonstrated
that caffeine consumption was significantly associated
with moderate to severe urinary incontinence in
United States men [12]. However, in stratified ana-
lyses by gender, no significant association was found
between coffee/caffeine consumption and UI risk in
both men and women.
We also analyzed type of incontinence as outcome. Four
studies provided results on risk of UI specific for type
(stress, urge, and mixed UI). To the best of our know-
ledge, the present study is the first meta-analysis that
summarized the association between coffee consumption
and risk of UI by type. Hannestad and colleagues
stated that coffee intake was associated with an in-
creased risk of stress UI [10]. However, we did not
observe any significant (positive or negative) relations
with UI subtypes in our study.
There are several strengths in the present meta-
analysis. First of all, when different ORs were provided
according to the different levels of coffee/caffeine con-
sumption, we could combine the results of subgroups
and calculated a common OR. Secondly, through visual
inspection of a funnel plot and Begg’s and Egger’s tests,
we observed no evidence of publication bias. Moreover,
our findings were robust and reliable based on the con-
sistent results from sensitivity analysis.
Some limitations in our study should be of concern.
Firstly, adjusted confounding factors varied among dif-
ferent studies. Several potential confounding factors
such as parity, BMI, smoking and water intake were not
considered in several articles. Secondly, although no sig-
nificant evidence of publication bias was observed, pub-
lication bias might be inevitable due to unpublished
studies or original data. Thirdly, categories of coffee/caf-
feine intake varied from articles, which might lead to
significant heterogeneity. Fourthly, due to the lack of
relevant studies, crucial influences of coffee/caffeine
consumption, including duration of coffee/caffeine in-
take and type of coffee/caffeine, had not been studied
enough. Furthermore, a dose-response analysis could
not be carried out due to the limited data provided by
the included studies.
Conclusion
In summary, to our knowledge, this is the first meta-
analysis to date on the association between coffee/caf-
feine intake and risk of UI. The results from this
meta-analysis of observational studies demonstrated
that coffee/caffeine consumption was not associated
with overall UI risk. Nevertheless, because of the
Fig. 7 Funnel plot for studies of coffee/caffeine consumption in relation to UI risk
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potential limitations of this meta-analysis, conclusions
must be drawn with caution, and more well-designed
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